What is driving obesity market growth and what does that mean for manufacturers?
Are GLP-1 weight-loss therapies growing primarily by expanding the treatment population or by capturing share from existing obesity therapies? Obesity afflicts...
Industries
Life Sciences
We bring clarity to complex challenges.
For more than 25 years, life science companies, law firms, and regulatory agencies around the globe have turned to CRA’s life sciences consultants when they need clarity and solutions to the industry’s most complex issues. Clients value our deep industry knowledge, rigorous analytic techniques, and decades of hands-on experience spanning thousands of successful engagements.
Engagements
- 01Assessing the market potential of an AI-enabled endoscopy technologyClient issue A leading pharmaceutical R&D company developed a prototype artificial intelligence (AI) model to assess inflammatory bowel disease severity, with...View engagement
- 02Life Sciences Practice supports efforts to harmonize newborn screening across EuropeDespite newborn screening (NBS) being one of the most successful public health interventions of the past century, profound inequalities in access persist...View engagement
- 03Judge cites CRA expert Dr. Josh Sherman's testimony in antitrust trial rulingJudge Bazak-Rapaport’s decision rejected the parties’ narrow relevant market definition and agreed with and cited Dr. Sherman’s testimony from his...View engagement
Contact a Life Sciences expert.
See all Life Sciences expertsLatest insights
Upcoming events
China’s Growing Role in Life Sciences: Preparing for the Next Wave of Cross-Border Disputes
As the center of life sciences innovation increasingly shifts to China, companies must be ready for a more complex international arbitration landscape. In this...
OBA Business Law Program "Advertising & Marketing Law: What’s New, What’s Next"
Daniel Shack is a panelist during the session titled “Survey Says…” In recent proceedings, consumer survey evidence has been tendered. What’s it for? What’s it...
Recent events
ABA United Against Fakes: The Counterfeit Drug Problem Webinar
Erin McDermott moderates the webinar examining the rise of counterfeit life sciences products, including illicit online pharmacies, unauthorized imports,,...
World Orphan Drug Congress EU 2026
Tim Wilsdon moderates the panel discussion titled “The Economic impact of living with a rare disease in APAC and LATAM – Regional solutions to inform a Global...